Gilead Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	29,736	29,443	28,754	27,116	27,281	27,305
Revenue Growth (YoY)	3.48%	2.40%	6.04%	-0.60%	-0.09%	10.60%
Cost of Revenue	6,139	6,234	6,251	6,498	5,657	6,601
Gross Profit	23,597	23,209	22,503	20,618	21,624	20,704
Selling, General & Admin	5,967	5,774	6,091	6,090	5,673	5,246
Research & Development	6,670	7,413	14,750	6,923	8,621	5,540
Total Operating Expenses	12,637	13,187	20,841	13,013	14,294	10,786
Operating Income	10,371	10,022	1,662	7,605	7,330	9,918
Interest Expense	-1,005	-1,024	-977	-944	-935	-1,001
Other Non-Operating Income (Expense)	1,361	798	6	198	-581	-639
Total Non-Operating Income (Expense)	356	-226	-971	-746	-1,516	-1,640
Pretax Income	10,728	9,796	690	6,859	5,814	8,278
Provision for Income Taxes	1,511	1,286	211	1,247	1,248	-2,077
Net Income	9,216	8,510	480	5,613	4,566	6,201
Minority Interest in Earnings	-	-	-	-52	-26	24
Net Income to Common	9,216	8,510	480	5,665	4,592	6,225
Net Income Growth	54.50%	1672.92%	-91.53%	23.37%	-26.23%	4960.98%
Shares Outstanding (Basic)	1,243	1,244	1,247	1,248	1,255	1,256
Shares Outstanding (Diluted)	1,254	1,255	1,255	1,258	1,262	1,262
Shares Change (YoY)	-0.14%	-	-0.24%	-0.32%	-	-0.08%
EPS (Basic)	7.42	6.84	0.38	4.54	3.66	4.96
EPS (Diluted)	7.34	6.78	0.38	4.50	3.64	4.93
EPS Growth	54.53%	1684.21%	-91.56%	23.63%	-26.17%	4830.00%
Free Cash Flow	9,639	9,456	10,305	7,421	8,344	10,805
Free Cash Flow Growth	1.93%	-8.24%	38.86%	-11.06%	-22.78%	40.40%
Free Cash Flow Per Share	7.69	7.53	8.21	5.90	6.61	8.56
Dividends Per Share	3.190	3.160	3.080	3.000	2.920	2.840
Dividend Growth	0.95%	2.60%	2.67%	2.74%	2.82%	4.41%
Gross Margin	79.36%	78.83%	78.26%	76.04%	79.26%	75.82%
Operating Margin	34.88%	34.04%	5.78%	28.05%	26.87%	36.32%
Profit Margin	30.99%	28.90%	1.67%	20.70%	16.74%	22.71%
FCF Margin	32.42%	32.12%	35.84%	27.37%	30.59%	39.57%
EBITDA	13,124	12,782	4,429	10,298	9,433	11,968
EBITDA Margin	44.14%	43.41%	15.40%	37.98%	34.58%	43.83%
EBIT	10,371	10,022	1,662	7,605	7,330	9,918
EBIT Margin	34.88%	34.04%	5.78%	28.05%	26.87%	36.32%
Effective Tax Rate	14.08%	13.13%	30.58%	18.18%	21.47%	-25.09%

SEC Filings: 10-K · 10-Q